JP2013544872A5 - - Google Patents

Download PDF

Info

Publication number
JP2013544872A5
JP2013544872A5 JP2013542577A JP2013542577A JP2013544872A5 JP 2013544872 A5 JP2013544872 A5 JP 2013544872A5 JP 2013542577 A JP2013542577 A JP 2013542577A JP 2013542577 A JP2013542577 A JP 2013542577A JP 2013544872 A5 JP2013544872 A5 JP 2013544872A5
Authority
JP
Japan
Prior art keywords
heterocycle
alkyl
alkynyl
alkenyl
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013542577A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013544872A (ja
JP6050241B2 (ja
Filing date
Publication date
Priority claimed from GBGB1021103.5A external-priority patent/GB201021103D0/en
Application filed filed Critical
Publication of JP2013544872A publication Critical patent/JP2013544872A/ja
Publication of JP2013544872A5 publication Critical patent/JP2013544872A5/ja
Application granted granted Critical
Publication of JP6050241B2 publication Critical patent/JP6050241B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013542577A 2010-12-13 2011-12-13 神経変性疾患の治療のための新規化合物 Expired - Fee Related JP6050241B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1021103.5A GB201021103D0 (en) 2010-12-13 2010-12-13 New compounds for the treatment of neurodegenerative diseases
GB1021103.5 2010-12-13
PCT/EP2011/072568 WO2012080221A1 (en) 2010-12-13 2011-12-13 New compounds for the treatment of neurodegenerative diseases

Publications (3)

Publication Number Publication Date
JP2013544872A JP2013544872A (ja) 2013-12-19
JP2013544872A5 true JP2013544872A5 (enExample) 2015-01-29
JP6050241B2 JP6050241B2 (ja) 2016-12-21

Family

ID=43567100

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013542577A Expired - Fee Related JP6050241B2 (ja) 2010-12-13 2011-12-13 神経変性疾患の治療のための新規化合物

Country Status (12)

Country Link
US (1) US9266832B2 (enExample)
EP (1) EP2651888B1 (enExample)
JP (1) JP6050241B2 (enExample)
CN (1) CN103261156B (enExample)
CA (1) CA2819171C (enExample)
DK (1) DK2651888T3 (enExample)
ES (1) ES2637288T3 (enExample)
GB (1) GB201021103D0 (enExample)
HR (1) HRP20171186T1 (enExample)
HU (1) HUE033277T2 (enExample)
SI (1) SI2651888T1 (enExample)
WO (1) WO2012080221A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201021104D0 (en) 2010-12-13 2011-01-26 Univ Leuven Kath Novel compounds for the treatment of neurodegenerative diseases
GB201021103D0 (en) 2010-12-13 2011-01-26 Univ Leuven Kath New compounds for the treatment of neurodegenerative diseases
US10266515B2 (en) * 2013-12-30 2019-04-23 Lifesci Pharmaceuticals, Inc. Therapeutic inhibitory compounds
EA032374B1 (ru) * 2014-01-29 2019-05-31 ЮСиБи БАЙОФАРМА СПРЛ Гетероарильные амиды в качестве ингибиторов агрегации белков
CN104744353B (zh) * 2015-03-31 2017-11-24 山东友帮生化科技有限公司 2‑氨基‑3‑碘‑5‑氯吡啶的合成方法
CN105130978B (zh) * 2015-07-22 2017-11-21 中国人民解放军军事医学科学院基础医学研究所 一种化合物及其在帕金森疾病方面的应用
US10975066B2 (en) 2015-07-29 2021-04-13 UCB Biopharma SRL Bis-heteroaryl derivatives as modulators of protein aggregation
EP3529245A4 (en) 2016-10-24 2020-12-23 Yumanity Therapeutics, Inc. COMPOUNDS AND USES OF THE LATEST
MA47212A (fr) 2017-01-06 2019-11-13 Yumanity Therapeutics Inc Méthodes de traitement de troubles neurologiques
CN110191885B (zh) 2017-01-26 2023-05-16 Ucb生物制药私人有限公司 作为蛋白质聚集调节剂的烷氧基双-杂芳基衍生物
RU2019126170A (ru) 2017-01-26 2021-02-26 Юсб Байофарма Спрл Бисгетероарильные производные в качестве модуляторов агрегации белков
US10889584B2 (en) 2017-01-26 2021-01-12 UCB Biopharma SRL Bicyclic bis-heteroaryl derivatives as modulators of protein aggregation
EP3589616A1 (en) 2017-02-28 2020-01-08 Universitat Autònoma de Barcelona (nitro-phenyl)-nitropyridine compounds for treating synucleinopathies
WO2019025424A1 (en) 2017-08-04 2019-02-07 Universitat Autonoma De Barcelona COMPOUNDS FOR TREATING SYNUCLEINOPATHIES
WO2019084157A1 (en) 2017-10-24 2019-05-02 Yumanity Therapeutics, Inc. COMPOUNDS AND USES THEREOF
WO2019161917A1 (en) 2018-02-23 2019-08-29 Universitat Autonoma De Barcelona 4-substituted 1-ethenylsulfonyl-2-nitrobenzene compounds for treating synucleinopathies
ES3043183T3 (en) 2018-03-23 2025-11-25 Janssen Pharmaceutica Nv Compounds and uses thereof
LT3860998T (lt) 2018-10-05 2024-06-25 Annapurna Bio Inc. Junginiai ir kompozicijos, skirti gydyti būkles, susijusias su apj receptoriaus aktyvumu
MA54829A (fr) 2019-01-24 2021-12-01 Yumanity Therapeutics Inc Composés et leurs utilisations
US20230078764A1 (en) * 2019-03-22 2023-03-16 Yumanity Therapeutics, Inc. Compounds and uses thereof
US12318357B2 (en) 2019-08-02 2025-06-03 Acelot, Inc. Small molecule drugs and related methods for treatment of diseases related to TDP-43, alpha-synuclein, huntingtin's protein and tau protein oligomer formation
EA202192047A1 (ru) 2019-11-13 2021-12-08 Юманити Терапьютикс, Инк. Соединения и их применение

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3345376A (en) 1963-11-06 1967-10-03 Upjohn Co Polyhydro-6-methoxy-1-(3, 4, 5-trimethoxyphenyl)-9h-pyrido[3, 4-b]indoles
IL130169A (en) 1999-05-27 2006-08-20 Neurim Pharma 1991 Derivatives of indole, and pharmaceutical, skin-protective and cosmetic compositions containing them
US6306890B1 (en) 1999-08-30 2001-10-23 Vanderbilt University Esters derived from indolealkanols and novel amides derived from indolealkylamides that are selective COX-2 inhibitors
GB9922171D0 (en) * 1999-09-21 1999-11-17 Zeneca Ltd Chemical compounds
US6852734B2 (en) 2000-05-02 2005-02-08 Meiji Seika Kaisha, Ltd. Indole derivatives exhibiting chymase-inhibitory activities and process for preparation thereof
DOP2002000332A (es) * 2001-02-14 2002-08-30 Warner Lambert Co Inhibidores de piridina de metaloproteinasas de la matriz
PT2476667E (pt) 2003-02-26 2014-09-18 Sugen Inc Compostos de aminoheteroarilo como inibidores da proteína quinase
JP2008505183A (ja) 2004-07-01 2008-02-21 ザ・レジェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア Pdz−ドメイン相互作用阻害小分子
EP1817025A2 (en) 2004-11-23 2007-08-15 PTC Therapeutics, Inc. Tetrahydrocarbazoles as active agents for inhibiting vegf production by translational control
CN101223136A (zh) 2005-07-12 2008-07-16 拜尔农科股份有限公司 新苯并杂环基乙基苯甲酰胺衍生物
EP2149552A1 (de) * 2008-07-30 2010-02-03 Bayer Schering Pharma AG 5,6 substituierte Benzamid-Derivate als Modulatoren des EP2-Rezeptors
WO2010100606A1 (en) * 2009-03-03 2010-09-10 Pfizer Inc. Novel phenyl imidazoles and phenyl triazoles as gamma-secretase modulators
GB0910003D0 (en) * 2009-06-11 2009-07-22 Univ Leuven Kath Novel compounds for the treatment of neurodegenerative diseases
ES2360435B1 (es) * 2009-10-30 2012-05-04 Consejo Superior De Investigaciones Cientificas (Csic) (70%) Derivados de biss (aralquil) amino y sistemas (6+5)-heteroaromaticos y su uso en el tratamiento de patologias neurodegenerativas, incluida la enfermedad de alzheimer
EP2622970A4 (en) 2010-09-29 2014-04-16 Ajinomoto Kk SALT TASTE AMPLIFIERS
SG10202010119TA (en) * 2010-11-15 2020-11-27 Abbvie Inc NAMPT And Rock Inhibitors
GB201021103D0 (en) 2010-12-13 2011-01-26 Univ Leuven Kath New compounds for the treatment of neurodegenerative diseases
GB201021104D0 (en) 2010-12-13 2011-01-26 Univ Leuven Kath Novel compounds for the treatment of neurodegenerative diseases

Similar Documents

Publication Publication Date Title
HRP20171186T1 (hr) Derivati n-((1h-indol-3-il)-alkil)-4-benzil)benzamida i n-((1h-pirolo[2,3b]piridin-3-il)-alkil)-4-benzil)benzamida kao inhibitori nakupljanja alfa sinukleina za liječenje neurodegenerativnih poremećaja
AU2019283837B2 (en) Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereof
CA2395717C (en) Fused imidazolium derivatives
AP848A (en) 6-Phenylpyridyl-2-amine derivatives useful as NOS inhibitors.
JPWO2010110231A1 (ja) 置換された3−ヒドロキシ−4−ピリドン誘導体
CA2961393A1 (en) Indoleamine-2,3-dioxygenase inhibitor and preparation method therefor
JP2017533968A5 (enExample)
JP2012513416A5 (enExample)
EP1601649A2 (en) A1 adenosine receptor antagonists
JP2018529690A5 (enExample)
WO2023018480A1 (en) Selective psychedelic compounds
JP2019529468A (ja) mGluR2陰性アロステリック調節剤としてのクロマン、イソクロマン及びジヒドロイソベンゾフラン誘導体、組成物、及びそれらの使用
RU2010113358A (ru) Гуанидинсодержащие соединения, применимые в качестве антагонистов мускариновых рецепторов
WO2016210345A1 (en) Composition and methods for inhibiting mammalian sterile 20-like kinase 1
EP2970128A1 (en) Base addition salts of nitroxoline and uses thereof
JP2024540303A5 (enExample)
WO2001042244A1 (en) Novel 1,8-naphthyridin-2(1h)-one derivatives
JP2015502371A5 (enExample)
US20150315130A1 (en) New positive allosteric modulators of nicotinic acetylcholine receptor
JPWO2006137465A1 (ja) 含窒素複素環誘導体
JP2021503451A5 (enExample)
US7419997B2 (en) Tetrahydrocarbazole derivatives and their pharmaceutical use
CA2289100A1 (en) Quinoline derivatives as pde iv and/or tnf inhibitors
US20120252853A1 (en) Positive allosteric modulators of nicotinic acetylcholine receptor
JP2003500393A (ja) 薬学的組成物およびその使用